Yüklüyor......
Manufacturing of recombinant adeno-associated viral vectors for clinical trials
The ability to elicit robust and long-term transgene expression in vivo together with minimal immunogenicity and little to no toxicity are only a few features that make recombinant adeno-associated virus (rAAV) vectors ideally suited for many gene therapy applications. Successful preclinical studies...
Kaydedildi:
| Yayımlandı: | Mol Ther Methods Clin Dev |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Nature Publishing Group
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4804725/ https://ncbi.nlm.nih.gov/pubmed/27014711 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mtm.2016.2 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|